Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-05-25 @ 1:55 AM
Study NCT ID:
NCT02294357
Status:
TERMINATED
Last Update Posted:
2023-11-01
First Post:
2014-11-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Sponsor:
Oncotherapeutics
Organization: